Table 2 Genotype and allele frequencies of BAFF rs2893321 in male or female subjects
From: Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
| Â | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|
Control n (%) | MG n (%) | χ2 | P | Control n (%) | MG n (%) | χ2 | P | |
Genotype | ||||||||
 AA | 28 (38.9%) | 22 (32.4%) | 3.821 | .148 | 24 (31.6%) | 39 (48.1%) | 6.145 | .046* |
 GA | 36 (50.0%) | 30 (44.1%) |  |  | 44 (57.9%) | 31 (38.3%) |  |  |
 GG | 8 (11.1%) | 16 (23.5%) |  |  | 8 (10.5%) | 11 (13.6%) |  |  |
Allele | ||||||||
 A | 92 (63.9%) | 74 (54.4%) | 2.603 | .107 | 92 (60.5%) | 109 (67.3%) | 1.555 | .212 |
 G | 52 (36.1%) | 62 (45.6%) |  |  | 60 (39.5%) | 53 (32.7%) |  |  |